Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production.

Cancer therapy Imaging agents Nanomedicine Nanotechnology Nanovaccines

Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 13 12 2018
accepted: 06 09 2019
pubmed: 19 9 2019
medline: 11 7 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

In the last decades, nanotechnology-based tools started to draw the attention of research worldwide. They offer economic, rapid, effective, and highly specific solutions for most medical issues. As a result, the international demand of nanomaterials is expanding very rapidly. It was estimated that the market of nanomaterials was about $2.6 trillion in 2015. In medicine, various applications of nanotechnology proved their potential to revolutionize medical diagnosis, immunization, treatment, and even health care products. The loading substances can be coupled with a large set of nanoparticles (NPs) by many means: chemically (conjugation), physically (encapsulation), or via adsorption. The use of the suitable loading nanosubstance depends on the application purpose. They can be used to deliver various chemicals (drugs, chemotherapeutic agents, or imaging substances), or biological substances (antigens, antibodies, RNA, or DNA) through endocytosis. They can even be used to deliver light and heat to their target cells when needed. The present review provides a brief overview about the structure and shape of available NPs and discusses their applications in the medical sciences.

Identifiants

pubmed: 31529348
doi: 10.1007/s11356-019-06459-2
pii: 10.1007/s11356-019-06459-2
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19200-19213

Auteurs

Amr El-Sayed (A)

Faculty of Veterinary Medicine, Department of Medicine and Infectious Diseases, Cairo University, Giza, Egypt.

Mohamed Kamel (M)

Faculty of Veterinary Medicine, Department of Medicine and Infectious Diseases, Cairo University, Giza, Egypt. m_salah@staff.cu.edu.eg.

Articles similaires

Humans COVID-19 Immunoglobulin G Antibodies, Viral SARS-CoV-2
Bangladesh Humans COVID-19 COVID-19 Vaccines SARS-CoV-2
1.00
Humans Female Papillomavirus Vaccines Male Young Adult
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Classifications MeSH